mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.8 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.015 |
0.8 |